The library does not have a dedicated laparoscopic cholecystectomy anesthesia chapter, but here is a comprehensive, well-structured answer based on established anesthesia principles:
Anesthetic Considerations for Laparoscopic Cholecystectomy
1. PREOPERATIVE ASSESSMENT
Patient factors to evaluate
| System | What to Check |
|---|
| Cardiovascular | IHD, HTN, arrhythmias - CO2 pneumoperitoneum stresses the heart |
| Respiratory | COPD, asthma, OSA - increased CO2 load and reduced compliance |
| Obesity | BMI, neck circumference, Mallampati - difficult airway + preoxygenation strategy |
| GI | GERD, hiatus hernia - high aspiration risk with head-down tilt |
| Coagulation | Jaundice, liver disease - affects coagulation |
| Medications | Anticoagulants (bridging?), antiplatelets |
Fasting
- Standard 6 hours solids / 2 hours clear fluids
- In acute cholecystitis or known GERD: treat as full stomach → RSI
2. CHOICE OF ANESTHESIA
General Anesthesia with Endotracheal Intubation (ETT) - STANDARD
- ETT with controlled mechanical ventilation is mandatory for laparoscopic cholecystectomy
- LMA is generally avoided (high IAP from pneumoperitoneum risks aspiration around LMA)
- Reasons for ETT:
- Protects airway from regurgitation (head-down position + raised IAP)
- Allows controlled IPPV to manage hypercapnia from CO2 absorption
- Secures airway against loss due to position changes
Can regional anesthesia be used?
- Not practical for standard laparoscopic cholecystectomy
- High spinal/epidural needed (T4 level) - uncomfortable with pneumoperitoneum
- General anesthesia is the standard of care
3. PHYSIOLOGICAL EFFECTS OF CO2 PNEUMOPERITONEUM
This is the most critical section - understanding these effects guides all intraoperative management.
A. Cardiovascular Effects
| Effect | Mechanism | Clinical Impact |
|---|
| ↑ SVR (systemic vascular resistance) | Raised IAP compresses aorta | ↑ Afterload → strain on heart |
| ↓ Venous return | IVC compression by raised IAP | ↓ Preload → ↓ CO initially |
| ↑ HR and BP | CO2 absorption → hypercarbia → sympathetic stimulation | Tachycardia, hypertension |
| Dysrhythmias | Hypercarbia + vagal stimulation during peritoneal stretch | Bradycardia, PVCs |
| Vagal bradycardia | Rapid peritoneal insufflation stimulates vagus | Severe bradycardia/cardiac arrest during trocar insertion |
IAP should be kept ≤12-15 mmHg to minimize cardiovascular compromise
B. Respiratory Effects
| Effect | Mechanism | Clinical Impact |
|---|
| ↑ PaCO2 | Systemic CO2 absorption from pneumoperitoneum | Respiratory acidosis |
| ↓ FRC | Raised diaphragm from IAP | Atelectasis, V/Q mismatch |
| ↑ Peak airway pressures | ↓ Compliance from raised diaphragm | Risk of barotrauma |
| Endobronchial intubation | Raised diaphragm pushes carina upward | ETT may slip into right main bronchus - recheck after insufflation |
Management: Increase minute ventilation (increase RR or TV) to maintain EtCO2 35-40 mmHg. Reduce IAP if EtCO2 uncontrollable.
C. Renal Effects
- ↓ Renal blood flow from IAP
- ↓ GFR - transient oliguria intraoperatively
- Usually reverses on deflation of pneumoperitoneum
D. Neurological
- Raised IAP → raised ICP (via raised intrathoracic pressure → impaired cerebral venous drainage)
- Relevant in patients with intracranial pathology
4. POSITION: REVERSE TRENDELENBURG + LEFT TILT
- Cholecystectomy uses reverse Trendelenburg (head up, feet down) + left lateral tilt
- This shifts liver/gallbladder upward into operative field
- Beneficial respiratory effect: Reduces diaphragmatic compression slightly compared to flat supine with pneumoperitoneum
- Risk: Venous pooling in legs → ↓ venous return → ↓ CO
- Counteracted with adequate IV fluids before tilting
- DVT risk - use pneumatic compression devices (TED stockings or calf compressors)
5. INDUCTION
| Step | Detail |
|---|
| Preoxygenation | 3-5 min 100% O2; head-up/ramped in obese patients (as discussed) |
| RSI consideration | If GERD, acute cholecystitis, or obese - use modified RSI with cricoid pressure |
| Induction agents | Propofol 1.5-2.5 mg/kg IV (preferred - antiemetic effect reduces PONV) |
| Muscle relaxant | Atracurium/Rocuronium for intubation and intraoperative paralysis |
| Analgesia | Fentanyl 1-2 mcg/kg at induction |
| Antiemetics | Ondansetron 4 mg + Dexamethasone 4-8 mg IV at induction (high PONV risk) |
6. MAINTENANCE
| Parameter | Strategy |
|---|
| Agent | Volatile (sevoflurane/isoflurane) OR TIVA with propofol infusion |
| Nitrous oxide (N2O) | AVOID - diffuses into bowel, distends gut, worsens surgical field, increases PONV |
| Muscle relaxation | Maintain full neuromuscular blockade intraoperatively (good surgical conditions, prevents bucking) |
| Ventilation | Controlled IPPV - increase minute ventilation to keep EtCO2 35-40 mmHg |
| PEEP | 5-8 cmH2O to prevent atelectasis (especially obese) |
| IAP monitoring | Keep insufflation pressure ≤12-15 mmHg |
| Fluid | Moderate - 2-4 mL/kg/hr; avoid overload |
| Temperature | Active warming - laparoscopy causes heat loss via CO2 |
7. MONITORING
| Monitor | Purpose |
|---|
| Standard ASA monitoring (SpO2, ECG, NIBP, EtCO2, temperature) | Mandatory |
| EtCO2 (capnography) | Most important - guides ventilation, detects CO2 embolism (sudden drop) |
| Airway pressures | Detect endobronchial intubation or pneumothorax |
| Neuromuscular monitoring (TOF) | Ensure adequate relaxation intraop; reversal at end |
| Urine output | Oliguria from raised IAP - monitor catheter |
8. COMPLICATIONS AND THEIR ANESTHETIC MANAGEMENT
| Complication | Recognition | Management |
|---|
| Vagal bradycardia (peritoneal stretch/trocar) | Sudden bradycardia during insufflation | Stop insufflation, Atropine 0.6 mg IV |
| CO2 embolism | Sudden ↓ EtCO2, ↓ SpO2, mill-wheel murmur, CVS collapse | Stop insufflation, left lateral/Durant position, aspirate via CVP, CPR if needed |
| Pneumothorax | ↑ Airway pressures, ↓ SpO2, unilateral breath sounds | Stop insufflation, decompress |
| Endobronchial intubation | ↓ SpO2 after position/insufflation | Pull ETT back 2-3 cm, recheck |
| Subcutaneous emphysema | CO2 tracking into tissues - crepitus, ↑ EtCO2 | Reduce IAP, may resolve; avoid N2O |
| Surgical emphysema → pneumomediastinum | ↑ EtCO2 refractory, neck crepitus | Deflate, may need postpone |
| Conversion to open | Bleeding, bile duct injury, adhesions | Prepare for rapid conversion; inform team |
9. PONV (Post-Operative Nausea and Vomiting) - HIGH RISK
Laparoscopic cholecystectomy is one of the highest PONV risk procedures (Apfel score often 3-4).
Risk factors present: female, non-smoker, laparoscopy, opioid use, peritoneal CO2 irritation
Triple prophylaxis protocol:
- Ondansetron 4 mg IV (at induction or end of surgery)
- Dexamethasone 4-8 mg IV (at induction)
- Avoid N2O + use propofol TIVA if high risk (TIVA reduces PONV vs volatiles)
- Consider droperidol or cyclizine as additional agent
10. REVERSAL AND EXTUBATION
| Step | Detail |
|---|
| Ensure deflation | Confirm all CO2 has been evacuated before extubation |
| Reverse NMB | Neostigmine 0.05 mg/kg + Glycopyrrolate 0.01 mg/kg; OR Sugammadex 2-4 mg/kg |
| Extubation | Awake extubation - patient must be responsive, adequate TOF ratio ≥0.9 |
| Position | Sit up / lateral during extubation in obese patients |
| Shoulder tip pain | Warn patient - referred phrenic nerve pain from CO2 irritating diaphragm; resolves in 24-48 hrs; NSAIDs help |
11. POSTOPERATIVE ANALGESIA (Multimodal)
| Drug | Dose/Route | Timing |
|---|
| Paracetamol | 1 g IV/oral 6 hourly | Regular |
| Ketorolac / Diclofenac | 30 mg IV / 75 mg IM | Intraop and postop |
| Local anaesthetic port site infiltration | Bupivacaine 0.25% at trocar sites | Before trocar insertion |
| Intraperitoneal LA | Bupivacaine 0.5% 20 mL intraperitoneally | At end of surgery |
| Opioids (tramadol/morphine) | PRN rescue only | Minimize to reduce PONV |
12. SPECIAL CONSIDERATIONS IN OBESE PATIENT
As discussed in the previous question - applies fully here:
- Ramped position, CPAP preoxygenation, video laryngoscopy
- Higher PEEP intraoperatively (10 cmH2O)
- Lung recruitment manoeuvres after pneumoperitoneum insufflation
- Sugammadex preferred over neostigmine for reversal (faster, more complete)
- Consider post-op HDU monitoring if BMI >45 or OSA
Quick Summary
Preop → Assess CVS/RS/Airway/GERD risk
Induction → RSI if needed, ETT mandatory, Propofol + Fentanyl + Muscle relaxant
Maintenance → Volatile/TIVA, NO nitrous, ↑MV for CO2, PEEP, full paralysis
Monitor → EtCO2 most critical, airway pressures, TOF
Complications → Vagal Brady, CO2 embolism, Pneumothorax, Endobronchial ETT
PONV → Triple prophylaxis (Ondansetron + Dexamethasone + TIVA)
Reversal → Awake extubation, Sugammadex preferred
Postop → Multimodal analgesia, warn about shoulder tip pain